dydrogesterone has been researched along with tibolone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altermatt, HJ; Bersinger, NA; Birkhaeuser, MH; Haenggi, W | 1 |
| Birkhaeuser, MH; Casez, JP; Haenggi, W; Jaeger, P; Lippuner, K | 1 |
| Birkhäuser, MH; Hänggi, W; Jaeger, P; Lippuner, K; Riesen, W | 1 |
| Altermatt, HJ; Bersinger, N; Birkhäuser, MH; Hänggi, W | 1 |
| Birkhäuser, MH; Hänggi, W; Horber, FF; Jaeger, P; Lippuner, K | 1 |
| Morin-Papunen, LC; Raudaskoski, T; Ruokonen, A; Tapanainen, JS; Vauhkonen, I | 1 |
| Chrystyn, H; Elfituri, A; Elmahaishi, M; Sherif, F | 1 |
| Franke, HR; Vermes, I; Werner, HM | 1 |
| Brinkhuis, M; Franke, HR; Jansen, GH; Vermes, I; Wolbers, F | 1 |
| Casarosa, E; Genazzani, AR; Giannini, A; Luisi, M; Merlini, S; Pluchino, N; Pot, E; Stomati, M; Valentino, V | 1 |
| Cunha, EP; Fernandes, CE; Mader, AM; Pinhal, MA; Pompei, LM; Silva, VF; Silveira, ER; Steiner, ML; Theodoro, TR | 1 |
| Cunha, EP; Fernandes, CE; Mader, AM; Petri, G; Pinhal, MA; Pompei, LM; Steiner, ML; Theodoro, TR | 1 |
8 trial(s) available for dydrogesterone and tibolone
| Article | Year |
|---|---|
Placental protein 14 (PP14) does not predict endometrial status under hormone replacement therapy.
Topics: Biopsy; Dydrogesterone; Endometrial Neoplasms; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Hyperplasia; Middle Aged; Norpregnenes; Postmenopause; Pregnancy Proteins | 1997 |
Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
Topics: Absorptiometry, Photon; Administration, Cutaneous; Administration, Oral; Anabolic Agents; Bone Density; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Patient Compliance; Progesterone Congeners; Retrospective Studies | 1997 |
Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.
Topics: Administration, Cutaneous; Administration, Oral; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoproteins; Middle Aged; Norpregnenes; Progesterone Congeners | 1997 |
Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
Topics: Administration, Cutaneous; Administration, Oral; Anabolic Agents; Biopsy; Cohort Studies; Dydrogesterone; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Middle Aged; Norpregnenes; Postmenopause; Progesterone Congeners; Time Factors; Ultrasonography; Uterine Hemorrhage | 1997 |
Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women.
Topics: Absorptiometry, Photon; Administration, Cutaneous; Administration, Oral; Body Composition; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes | 1998 |
Effects of tibolone and cyclic hormone replacement therapy on glucose metabolism in non-diabetic obese postmenopausal women: a randomized study.
Topics: Area Under Curve; Blood Glucose; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Fatty Acids, Nonesterified; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Linear Models; Lipid Metabolism; Middle Aged; Norpregnenes; Obesity; Oxidation-Reduction; Postmenopause | 2004 |
Two hormone replacement therapy (HRT) regimens for middle-eastern postmenopausal women.
Topics: Administration, Oral; Adult; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Libya; Longitudinal Studies; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Severity of Illness Index; Treatment Outcome; White People | 2005 |
Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality.
Topics: Climacteric; Dehydroepiandrosterone; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Female; Follow-Up Studies; Gonadal Steroid Hormones; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Postmenopause; Radioimmunoassay; Sexuality; Surveys and Questionnaires; Treatment Outcome | 2011 |
4 other study(ies) available for dydrogesterone and tibolone
| Article | Year |
|---|---|
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured | 2005 |
Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dydrogesterone; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Hormone Replacement Therapy; Humans; In Vitro Techniques; Norpregnenes; Progestins; Receptors, Estrogen; RNA, Messenger | 2008 |
Is expression of rat breast matrix components influenced by estrogen, progestins and tibolone?
Topics: Animals; Biomarkers; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Extracellular Matrix; Female; Glucuronidase; Heparan Sulfate Proteoglycans; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Proliferating Cell Nuclear Antigen; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction | 2015 |
Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis.
Topics: Animals; Apoptosis; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Random Allocation; Rats; Rats, Wistar | 2015 |